在骨科领域，公司的第二款重点产品——用于膝关节前交叉韧带重建手术的可降解镁界面螺钉，已进入临床试验的关键阶段， 入组进度顺利。该产品旨在促进肌腱与骨骼的愈合。与此同时，面向脊柱融合手术的可降解镁融合器也在研发中，以解决传统 产品相容性不足等问题。 公司的研发布局也已扩展到口腔科和血管外科等新领域。针对口腔修复场景的镁基牙膜正在开发，其安全可降解的特性有望填 补市场空白；而处于实验室阶段的高纯镁支架，未来则可能应用于心血管或消化道，凭借可完全降解的特性，避免传统永久植 入体可能带来的长期风险。 这一切多品类布局的背后，是宜安科技在医用高纯镁材料上建立的技术基石。公司掌握了超高纯医用镁的提纯与制造核心技 术，从源头上保障了产品的生物安全性。同时，公司还能够根据不同的临床需求，对材料的降解速率和力学性能进行精确调 控。相关研发项目也已获得国家层面的重点支持，正在加速推进技术成果的转化与落地。 从一款骨钉切入市场，到规划覆盖骨科、口腔、血管介入等多个领域的产品线，宜安科技正以可降解镁材料为核心，打造一个 高附加值的医疗植入产品平台。在全球可降解医用镁市场蓬勃发展的背景下，公司凭借先发技术优势和全产业链能力，不仅有 望 ...

宜安科技（300328.SZ）1月5日在投资者互动平台表示，您好！感谢您对公司的关注。公司第一款可降 解镁骨内固定螺钉的补正材料，目前尚有部分问题点正在进一步与评审老师沟通确认，待所有问题点明 确解决后，公司将立即启动补正材料的正式提交程序，谢谢！ 每经AI快讯，有投资者在投资者互动平台提问：请问公司的镁骨钉注册补正工作推进到哪一步了？公 司预计多久能完成注册审批？ （记者 曾健辉） ...

Core Viewpoint - Yian Technology (300328) is actively advancing the registration and approval process for its biodegradable magnesium bone fixation screws, in compliance with the requirements of the National Medical Products Administration (NMPA) [1] Group 1 - The company emphasizes the importance of the registration approval work for its magnesium bone fixation screws [1] - The registration approval process is currently ongoing, with the completion time dependent on the NMPA's approval results [1] - The company is in the process of supplementing application materials, and once approved, the biodegradable magnesium bone fixation screw products will be ready for production and market sales [1]

近日，国家金融监督管理总局东莞监管分局披露了一批罚单，富德生命人寿、阳光财产保险和泰康人寿 保险等三家保险公司因违规被罚。其中，泰康人寿保险被罚款最多，为25万元。 南方财经全媒体记者程浩 东莞报道 本期看点：东莞银行被罚款超百万元；东莞泰康人寿、阳光财保等多家保险公司因违规被罚；东莞科技 金融"接力护航"行动举措"二十条"出台；楚天龙股东温州一马拟减持1383.41万股套现1.85亿元；利扬芯 片2024年净利润大幅亏损，同比大幅下降383.69%；宜安科技可降解镁骨内固定螺钉注册申请获受理。 1、金融要闻东莞银行被罚款超百万元 近日，国家金融监督管理总局东莞监管分局发布的2025年7、8号行政处罚显示，东莞银行、东莞银行东 莞分行厚街支行两名工作人员被罚，罚款数额合计达到110万元。 具体来看，东金罚决字〔2025〕7号显示，因股东股权管理不到位，未穿透认定主要股东关联方，东莞 银行股份有限公司被罚款25万元。东金罚决字〔2025〕8号显示，因贷款三查不严，大额关联授信风险 管控不到位，时任东莞银行东莞分行厚街支行行长、东莞银行东莞分行厚街支行公司客户经理被警告， 东莞银行东莞分行被罚款85万元。 东莞泰 ...

Group 1 - Jinguang Electric won a bid for a State Grid procurement project worth 66.6956 million yuan, accounting for 8.97% of the company's projected 2024 revenue [1] - Yian Technology's biodegradable magnesium bone fixation screws received acceptance from the National Medical Products Administration [1] - East China Pharmaceutical's subsidiary received approval for clinical trials of HDM2005 for treating diffuse large B-cell lymphoma [1][2] Group 2 - New Hope reported April pig sales of 1.596 million heads, with revenue of 2.278 billion yuan, showing a month-on-month increase of 2.92% [3] - Yingfang Software received a government subsidy of 5.4 million yuan related to its earnings [4] - Hanyu Pharmaceutical's subsidiary's liraglutide raw material received acceptance from South Korea's MFDS [5] Group 3 - Tianshan Co. announced that its controlling shareholder pledged not to reduce holdings for 12 months [6] - Huaren Pharmaceutical's subsidiary obtained a medical device registration certificate for a disposable sliding mat [8] - Hanma Technology reported April truck sales of 1,127 units, a year-on-year increase of 56.96% [9] Group 4 - Huatai Co. successfully commissioned a 700,000-ton chemical wood pulp project [10] - Green Ecology's subsidiary won a bid for a tourism infrastructure project in Sanqingshan, with a bid amount of 238 million yuan [12] - Zhonghua Rock and Soil's subsidiary won a bid for the Urumqi Airport expansion project worth 181 million yuan [13] Group 5 - Aohua High-tech signed a contract for an optical system development worth 297 million yuan, representing 39.84% of its projected 2024 revenue [15] - Linglong Tire's controlling shareholder plans to increase its stake by 200 to 300 million yuan [17] - Tianbang Food reported April sales of 470,900 pigs, generating revenue of 691 million yuan [20] Group 6 - Weisheng Information won a project from State Grid Hebei Power Company worth 15.4587 million yuan [21] - Haon Automotive received a product designation letter from a leading new energy vehicle brand, with an estimated total revenue of 619 million yuan over the project's lifecycle [22] - Mingpu Optical Magnetic's subsidiary obtained a patent for an inductance testing machine [23] Group 7 - Dongni Electronics received a government subsidy of 3.82 million yuan, accounting for 33.17% of its projected 2024 net profit [24] - Xibu Animal Husbandry reported April fresh milk production of 3,024.95 tons, a year-on-year increase of 0.47% [25] - Jianke Intelligent obtained multiple patent certificates and an international trademark registration [26] Group 8 - Roman Co. won a bid for a 100MW photovoltaic power station project worth 403 million yuan [26] - Chenguang Biological obtained several patent certificates, including one in Europe [26] - Hengxing Technology's subsidiary received a government subsidy of 2 million yuan [27] Group 9 - Guanshi Technology's executives plan to reduce their holdings by a total of 359,400 shares [28] - Softcom Power's shareholder plans to reduce its stake by up to 1% [29] - Fuchuang Precision's major shareholder plans to increase its stake by 120 to 240 million yuan [29] Group 10 - Laofengxiang's subsidiary signed a strategic cooperation agreement with Shanghai Jiushi Sports [31] - Xingye Silver Tin plans to issue up to 300 million USD in overseas bonds [32] - *ST Gongzhi faces delisting due to financial report issues [34]

宜安科技（300328）公告，公司收到国家药品监督管理局核发的可降解镁骨内固定螺钉境内医疗器械注 册申请受理通知书(受理号：CQZ2500780)。该产品以纯度为99.99wt.%的高纯镁制成，用于保髋治疗微 创手术，能促进骨成型并在体内逐渐降解，避免二次手术取出。若产品注册审评通过，将进一步丰富公 司产品布局，增强公司核心竞争力。 ...